Form C/A Curastory Inc.

  
    C/A
    
      
        
          0001802405
          XXXXXXXX
        
        020-28590
      
      LIVE
      
        false
        false
        false
      
    
  
  
    
      true
      The Company has increased the maximum offering amount, has updated its disclosure regarding previous securities offerings, and has added disclosure regarding its ongoing concurrent private securities offering.
      
        Curastory Inc.
        
          Corporation
          DE
          08-23-2019
        
        
          284 HUMBOLDT ST
          #5E
          BROOKLYN
          NY
          11206
        
        www.curastory.co
      
      N
      OpenDeal Portal LLC
      0001751525
      007-00167
      283874
    
    
      At the conclusion of the offering, the issuer shall pay a fee of six percent (6%) of the amount raised in the offering to the Intermediary.
      The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the offering.
      Other
      Crowd SAFE (Simple Agreement for Future Equity)
      25000
      1.00000
      Arbitrary
      25000.00
      Y
      Other
      At the Intermediary's discretion
      535000.00
      01-27-2022
    
    
      0.00
      90498.00
      667.00
      9891.00
      667.00
      0.00
      0.00
      80318.00
      10463.00
      157563.00
      0.00
      15000.00
      0.00
      0.00
      0.00
      709.00
      0.00
      -154103.00
      -12564.00
      AL
      AK
      AZ
      AR
      CA
      CO
      CT
      DE
      DC
      FL
      GA
      HI
      ID
      IL
      IN
      IA
      KS
      KY
      LA
      ME
      MD
      MA
      MI
      MN
      MS
      MO
      MT
      NE
      NV
      NH
      NJ
      NM
      NY
      NC
      ND
      OH
      OK
      OR
      PA
      PR
      RI
      SC
      SD
      TN
      TX
      UT
      VT
      VA
      WA
      WV
      WI
      WY
    
    
      
        Curastory Inc.
        Tiffany Kelly
        CEO & Director
      
      
        
          Tiffany Kelly
          CEO & Director
          09-21-2021
        
      
    
  

You May Also Be Interested In

• Best’s Market Segment Report: Underwriting Conditions for UAE Insurers on Track to Improve Amid IFRS 17 Transition
• Summit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen Harrison
• Equinor to commence second tranche of the 2024 share buy-back programme